Literature DB >> 8424448

Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.

K Hasegawa1, H Fujiwara, K Doyama, M Mukoyama, K Nakao, T Fujiwara, H Imura, C Kawai.   

Abstract

Although brain natriuretic peptide is expressed in ventricles of failing hearts including dilated cardiomyopathy, its morphological localization is still unclear. In this study, we analyzed the immunohistocytochemical localization of atrial and brain natriuretic peptides in ventricles of dilated cardiomyopathy at both light and electron microscopic levels. Ventricular specimens were obtained by endomyocardial biopsy in 31 patients (26 with dilated cardiomyopathy and 5 controls without any specific cardiac disease). By light microscopic immunohistochemistry using specific monoclonal antibodies, all (26 of 26) of the left ventricular endomyocardial biopsy specimens and 31% (8 of 26) of the right ventricular specimens showed immunoreactivity for both of these natriuretic peptides in dilated cardiomyopathy. In contrast, none of the normal controls showed immunoreactivity for either of these peptides. The percentage of atrial natriuretic peptide-containing or brain natriuretic peptide-containing myocytes in the left ventricular specimens showed an inverse correlation with the left ventricular ejection fraction (r = -0.72 and r = -0.69, respectively). By electron microscopy, we identified specific secretory granules in ventricular myocytes from patients with dilated cardiomyopathy, but not in those from normal controls. Double immunocytochemistry using a two-face immunogold staining method revealed brain natriuretic peptide colocalized with atrial natriuretic peptide in the same ventricular granules. These findings suggest that brain natriuretic peptide is expressed in ventricular myocytes in response to hemodynamic stress in dilated cardiomyopathy. Brain natriuretic peptide may be, at least in part, synthesized simultaneously and secreted together with atrial natriuretic peptide by granules from failing ventricles, although the secretory turnover is different between these two peptides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424448      PMCID: PMC1886835     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Endomyocardial biopsy.

Authors:  S SAKAKIBARA; S KONNO
Journal:  Jpn Heart J       Date:  1962-11

2.  Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.

Authors:  K Hosoda; K Nakao; M Mukoyama; Y Saito; M Jougasaki; G Shirakami; S Suga; Y Ogawa; H Yasue; H Imura
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

3.  Enzyme-labeled antibodies: preparation and application for the localization of antigens.

Authors:  P K Nakane; G B Pierce
Journal:  J Histochem Cytochem       Date:  1966-12       Impact factor: 2.479

4.  New endomyocardial biopsy catheter for the left ventricle.

Authors:  C Kawai; Y Kitaura
Journal:  Am J Cardiol       Date:  1977-07       Impact factor: 2.778

5.  Left ventricular volume and mass from single-plane cineangiocardiogram. A comparison of anteroposterior and right anterior oblique methods.

Authors:  J W Kennedy; S E Trenholme; I S Kasser
Journal:  Am Heart J       Date:  1970-09       Impact factor: 4.749

6.  Double immunocytochemical labeling applying the protein A-gold technique.

Authors:  M Bendayan
Journal:  J Histochem Cytochem       Date:  1982-01       Impact factor: 2.479

Review 7.  Ventricular wall stress.

Authors:  F C Yin
Journal:  Circ Res       Date:  1981-10       Impact factor: 17.367

8.  Myocarditis and endomyocardial biopsy.

Authors:  W D Edwards
Journal:  Cardiol Clin       Date:  1984-11       Impact factor: 2.213

9.  Left ventricular stresses in the intact human heart.

Authors:  I Mirsky
Journal:  Biophys J       Date:  1969-02       Impact factor: 4.033

10.  Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy.

Authors:  G Takemura; H Fujiwara; M Mukoyama; Y Saito; K Nakao; A Kawamura; M Ishida; M Kida; T Uegaito; M Tanaka
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

View more
  9 in total

1.  Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress.

Authors:  Koji Otsuka; Fumio Terasaki; Hiroaki Shimomura; Bin Tsukada; Taiko Horii; Tadashi Isomura; Hisayoshi Suma; Yuro Shibayama; Yasushi Kitaura
Journal:  Heart Vessels       Date:  2010-09-29       Impact factor: 2.037

2.  Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming.

Authors:  Kathryn M Spitler; Jessica M Ponce; Gavin Y Oudit; Duane D Hall; Chad E Grueter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 4.733

3.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

Authors:  J W Knowles; G Esposito; L Mao; J R Hagaman; J E Fox; O Smithies; H A Rockman; N Maeda
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

4.  Cardiac chamber-specific alterations of ANP and BNP expression with advancing age and with systemic hypertension.

Authors:  V Raizada; K Thakore; W Luo; P G McGuire
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

Review 5.  B-type natriuretic Peptide and the right heart.

Authors:  Lok Bin Yap
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

6.  ANP expression in the hypertensive heart.

Authors:  Gania Kessler-Icekson; Yael Barhum; Jutta Schaper; Wolfgang Schaper; Ella Kaganovsky; Thomas Brand
Journal:  Exp Clin Cardiol       Date:  2002

7.  FHL2 binds calcineurin and represses pathological cardiac growth.

Authors:  Berdymammet Hojayev; Beverly A Rothermel; Thomas G Gillette; Joseph A Hill
Journal:  Mol Cell Biol       Date:  2012-07-30       Impact factor: 4.272

Review 8.  Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction.

Authors:  Kailash N Pandey
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

Review 9.  Biochemistry of the Endocrine Heart.

Authors:  Jens P Goetze; Emil D Bartels; Theodor W Shalmi; Lilian Andraud-Dang; Jens F Rehfeld
Journal:  Biology (Basel)       Date:  2022-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.